Market

This Mumbai meditech company is set to become the first to list on BSE’s startup platform

Updated : September 03, 2019 09:01 PM IST

The Mumbai-based maker of therapeutic devices had opened its maiden IPO on August 26, 2019 at an issue size of 104,000 equity shares of face value Rs 10 each at Rs 130 a share.

Transpact received regulatory approvals to list on the BSE Start-up Platform on August 20, 2019.

Transpact Enterprises is due to become the first startup to list on the Bombay Stock Exchange’s (BSE) platform for such enterprises on September 5, 2019.

The Mumbai-based maker of therapeutic devices had opened its maiden IPO on August 26, 2019 at an issue size of 104,000 equity shares of face value Rs 10 each at Rs 130 a share.

The company will use the proceeds of the IPO to acquire an R&D facility and registered office, conduct further clinical studies for new disorders, redeem preferential shares and for working capital, it said in a statement.

Transpact received regulatory approvals to list on the BSE Start-up Platform on August 20, 2019. The IPO was fully subscribed on Day 3.

The company was incubated at the Society for Innovation and Entrepreneurship and Indian Institute of Technology, Bombay.

This Mumbai meditech company is set to become the first to list on BSE’s startup platform

You May Also Like

India reports 3.1% GDP growth in Q4; agriculture and mining surprise positively but manufacturing slips

Big revision in numbers lead to 4.2% growth in FY20, Q4 GDP comes at 3.1%

RedBus lost Rs 1,000 crore GMV during lockdown, industry lost out on 75 million tickets

Trending on CNBC-TV18

recommended for you